InVitro International | Balance Sheet

Fiscal year is October-September. All values USD Thousands.
2015
2016
2017
2018
Cash & Short Term Investments
650.60
836.60
856.80
911.30
Total Accounts Receivable
93.90
67.70
99.10
86.40
Inventories
140.70
130.70
128.30
134.10
Other Current Assets
20.60
26.30
26.30
44.20
Total Current Assets
905.70
1,061.20
1,110.40
1,176.10
Net Property, Plant & Equipment
52.70
37.60
29.40
16.70
Intangible Assets
9.40
8.60
6.90
5.20
Other Assets
3.40
3.40
14.00
9.80
Total Assets
971.30
1,110.80
1,160.70
1,207.90
Accounts Payable
23.30
2.70
11.70
Income Tax Payable
-
2.80
-
Other Current Liabilities
56.90
71.40
62.50
Total Current Liabilities
80.20
77.00
74.10
Total Liabilities
80.20
77.00
74.10
Common Equity (Total)
891.10
1,033.90
1,086.60
Total Shareholders' Equity
891.10
1,033.90
1,086.60
Total Equity
891.10
1,033.90
1,086.60
Liabilities & Shareholders' Equity
971.30
1,110.80
1,160.70

About InVitro International

View Profile
Address
330 East Orangethorpe Avenue
Placentia California 92870
United States
Employees -
Website http://www.invitrointl.com
Updated 07/08/2019
InVitro International engages in the provision of non-animal testing methods. Its products include Irritection, Corrositex, and Lab Services. The company was founded in September 1985 and is headquartered in Irvine, CA.